Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick M Hecht

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
AIDS (London, England)|July 14, 2018
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1Christina C Chang, Vivek Naranbhai, Jared Stern, et al.
AIDS (London, England)|December 20, 2003
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infectionMarcus Altfeld, Marylyn M Addo, Eric S Rosenberg, et al.
The Journal of Infectious Diseases|February 26, 2015
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV TherapySusanne von Stockenstrom, Lina Odevall, Eunok Lee, et al.
Nature Medicine|November 23, 2006
Microbial translocation is a cause of systemic immune activation in chronic HIV infectionJason M Brenchley, David A Price, Timothy W Schacker, et al.
Plos Pathogens|August 29, 2014
Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individualsNichole R Klatt, Steven E Bosinger, Melicent Peck, et al.
Cell Reports|November 21, 2015
Gut-Resident Lactobacillus Abundance Associates with IDO1 Inhibition and Th17 Dynamics in SIV-Infected MacaquesIvan Vujkovic-Cvijin, Louise A Swainson, Simon N Chu, et al.
Plos Pathogens|January 8, 2016
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV InfectionGlen M Chew, Tsuyoshi Fujita, Gabriela M Webb, et al.
Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.
Nature Immunology|October 24, 2007
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsMatthew J Dolan, Hemant Kulkarni, Jose F Camargo, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
AIDS (London, England)|July 14, 2018
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1Christina C Chang, Vivek Naranbhai, Jared Stern, et al.
AIDS (London, England)|December 20, 2003
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infectionMarcus Altfeld, Marylyn M Addo, Eric S Rosenberg, et al.
The Journal of Infectious Diseases|February 26, 2015
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV TherapySusanne von Stockenstrom, Lina Odevall, Eunok Lee, et al.
Nature Medicine|November 23, 2006
Microbial translocation is a cause of systemic immune activation in chronic HIV infectionJason M Brenchley, David A Price, Timothy W Schacker, et al.
Plos Pathogens|August 29, 2014
Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individualsNichole R Klatt, Steven E Bosinger, Melicent Peck, et al.
Cell Reports|November 21, 2015
Gut-Resident Lactobacillus Abundance Associates with IDO1 Inhibition and Th17 Dynamics in SIV-Infected MacaquesIvan Vujkovic-Cvijin, Louise A Swainson, Simon N Chu, et al.
Plos Pathogens|January 8, 2016
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV InfectionGlen M Chew, Tsuyoshi Fujita, Gabriela M Webb, et al.
Plos Pathogens|May 17, 2014
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortalitySergio Serrano-Villar, Talia Sainz, Sulggi A Lee, et al.
Nature Immunology|October 24, 2007
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsMatthew J Dolan, Hemant Kulkarni, Jose F Camargo, et al.
Pageof 25